Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1995
Buy Report Download FREE Resources

Published: November 11, 2022 Report Code: GDHC0041CHR-ST

Select Item

Sweden Healthcare Market Overview

The Sweden pharmaceutical market size was SEK 53.4 billion ($6.2 billion) in 2021. Likewise, the Swedish medical devices market size was $2.1 billion in 2021. The market will achieve a CAGR of more than 3% during 2022-2027. The growing aging population; lifestyle-related disease conditions such as diabetes and obesity; and increased prevalence of chronic diseases such as cardiovascular conditions, stroke, and cancer will drive the Sweden’s healthcare market growth.

The Sweden healthcare market research report is an essential source of information on the analysis of the healthcare, regulatory, and reimbursement landscape in Sweden. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

Sweden Pharmaceutical Market Overview 2021-2027 (SEK Billion)

Sweden Pharmaceutical Market Overview 2021-2027 (SEK Billion)

Buy the Full Report to Gain More Information on the Sweden Pharmaceutical Market Forecast

Download a Free Report Sample

   Market Size (Pharmaceutical Market) (2021)   SEK 53.4 billion ($6.2 billion)
   Key Segments    Generics, Biologics, Biosimilars, and Over-the-Counter (OTC) Medicines
   Key Import Partners    Belgium, the US, Denmark, the Netherlands, and Germany
   Key Export Partners    Germany, China, the US, Japan, and Norway
   Leading Players    Pfizer, Sanofi, SOBI, GlaxoSmithKline (GSK), and Novartis
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Sweden Medical Devices Market Overview 2021-2027 ($ Billion)

Sweden Medical Devices Market Overview 2021-2027 ($ Billion)

Buy the Full Report to Gain More Information on the Sweden Medical Device Market Forecast

Download a Free Report Sample

   Market Size (Medical Devices) (2021)    $2.1 billion
   CAGR (2022-2027)    >3%
   Key Segments   Hospital Supplies, Cardiovascular Devices, General Surgery Devices,   Orthopedic Devices, and Wound Care Management
   Leading Players    Abbott, Medtronic, Stryker, Alcon, and Getinge
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Sweden Pharmaceuticals Market Segmentation by Import and Export Partners

The key import partners of pharmaceutical products in Sweden are Belgium, the US, Denmark, the Netherlands, and Germany among others. Germany accounts for the highest percentage of the import business. The key export partners of Swedish pharmaceutical products are Germany, China, the US, Japan, and Norway, among others, in 2021. The US accounts for the highest percentage of the export business.

The key import partners of pharmaceutical products in Sweden are Belgium, the US, Denmark, the Netherlands, and Germany among others. Germany accounts for the highest percentage of the import business. In 2021, the key export partners of Swedish pharmaceutical products are Germany, China, the US, Japan, and Norway, among others. The US accounts for the highest percentage of the export business.

Sweden Pharmaceuticals Market Analysis by Import Partners

Sweden Pharmaceuticals Market Analysis by Import Partners

Buy the Full Report for More Import Partner Insights into the Sweden Healthcare Market

Download a Free Report Sample

Sweden Pharmaceuticals Market Analysis by Export Partners, 2021 (%)

Sweden Pharmaceuticals Market Analysis by Export Partners, 2021 (%)

Buy the Full Report for More Export Partner Insights into the Sweden Healthcare Market

Download a Free Report Sample

Sweden Pharmaceuticals and Medical Devices Market by Segments

The key segments in the Sweden pharmaceuticals market are generics, biologics, biosimilars, and over the counter (OTC) medicines. Meanwhile, the main medical devices segments in the market are hospital supplies, cardiovascular devices, general surgery devices, orthopedic devices, and wound care management among others. In 2021, hospital supplies accounted for the highest share of Sweden’s medical devices market.

Sweden Medical Devices Market Analysis by Segments

Sweden Medical Devices Market Analysis by Segments, 2021 (%)

Buy the Full Report for More Segment Insights into the Sweden Heathcare Market

Download a Free Report Sample

Sweden Pharmaceuticals Market – Competitive Landscape

The leading players in the Sweden pharmaceuticals market are:

  • Pfizer
  • Sanofi
  • SOBI
  • GlaxoSmithKline (GSK)
  • Novartis

Pfizer: Pfizer is headquartered in the US. In Sweden, it operates from Sollentuna. It is a research-based global biopharmaceutical company that discovers, develops, manufactures, and commercializes drugs for various conditions, consumer healthcare products, generics, and active pharmaceutical ingredients (APIs). The company focuses its R&D efforts on immunology and inflammation and cardiovascular and metabolic diseases, among others.

Sweden Pharmaceuticals Market Analysis by Players, 2021 (%)

Sweden Pharmaceuticals Market Analysis by Players, 2021 (%)

Buy the Full Report to Know More about the Leading Players in the Sweden Pharmaceuticals Market

Download a Free Report Sample

Sweden Medical Devices Market – Competitive Landscape

The major players in the Swedish medical devices market are:

  • Abbott
  • Medtronic
  • Stryker
  • Alcon
  • Getinge

Abbott: Abbott is headquartered in Abbott Park, Illinois, US. Its Sweden office is in Hemvärnsgatan, Solna. It is a diversified health product company that manufactures and markets drugs, diagnostics, branded generics, vascular products, and nutritional products. Abbott’s products comprise specialized medicines, medical diagnostic instruments and tests, minimally invasive surgical devices, and products for veterinary care. Geographically diverse operations assist Abbott in mitigating the various risks associated with an overdependence on a particular market.

Sweden Medical Devices Market Analysis by Players, 2021 (%)

Sweden Medical Devices Market Analysis by Players, 2021 (%)

Buy the Full Report to Know More about the Leading Players in the Sweden Medical Devices Market

Download a Free Report Sample

Scope

The report provides:

  • Information on the healthcare, regulatory, and reimbursement landscape in Sweden.

  •  An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.

  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Sanofi, Novartis, GlaxoSmithKline (GSK), and Sobi.

  • Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Stryker, Alcon, and Getinge.

  • An insightful review of the COVID-19 epidemiology, impact, developments in the healthcare market, HealthTech landscape, reimbursement, and regulatory landscape. The report also analyzes details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.

  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.

  • An overview of the opportunities and challenges to Swedish healthcare market growth.

Reasons to Buy

  • This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Indonesian healthcare market

  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Indonesian healthcare market in the future

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1. Table of Contents

1.1 List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights: Facts About the Sweden Healthcare Market

2.3 Key Highlights: Healthcare Startups in Sweden

2.4 Key Events: Sweden Healthcare Timeline, 2016–22

2.5 Key Events: Sweden Pharmaceutical Market

2.6 Key Events: M&As, VC, and PE Deals, Global Pharmaceutical Market, 2021–22

2.7 Key Events: Top Completed Deals by Value, 2021–22

2.8 Country Profile, Sweden, 2021

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Sweden

3.5 Pharmaceutical Market – Market Segments

3.6 Pharmaceutical Market – Market Segments, Generics, Sweden

3.7 Pharmaceutical Market – Market Segments, Biologics and Biosimilars, Sweden

3.8 Pharmaceutical Market – Market Segment, Over-the-Counter Medicines, Sweden

3.9 Pharmaceutical Market – Major Therapeutic Areas, Sweden

3.10 COVID-19 Epidemiology, Sweden

3.11 COVID-19 Impact and Developments in the Healthcare Market, Sweden

3.12 COVID-19 Clinical Trials Landscape, Sweden

3.13 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Sweden, 2020–22

6.2 Deal Analysis: Medical Devices Market, Sweden, 2020–22

7. Healthtech Landscape

7.1 Healthtech Landscape, Sweden

7.2 Healthtech Deals Landscape, Sweden

7.3 Key Healthtech Deals, Sweden

7.4 Adoption of Technology in Healthcare, Sweden

7.5 Digital Statistics, Sweden

7.6 Major Digital Regulations, Sweden

7.7 Digital Health – Benefits and Risks, Sweden

8. Market Access

8.1 Overview of Healthcare System, Sweden

8.2 Reimbursement Landscape, Sweden

8.3 Overview of Insurance Providers, Insurance, Sweden

8.4 Healthcare Spending and Prescription Drug Price Trends, Sweden

8.5 Pricing Policies, Sweden

8.6 Market Access: Key Events Timeline, Taiwan, 2010–24

8.7 Regulatory Landscape, Sweden

8.7.1 Marketing Authorization for Pharmaceutical Products, Sweden

8.7.2 Marketing Authorization for Biosimilars, Sweden

8.7.3 Marketing Authorization for Medical Devices, Sweden

8.7.4 Pharmaceutical and Medical Device Establishment Regulations, Sweden

8.7.5 Intellectual Property Rights, European Patent, Sweden

8.7.6 Intellectual Property Rights, European Unitary Patent, Sweden

8.7.7 Intellectual Property Rights, Patents, Sweden

8.7.8 Intellectual Property Rights, Trademark, Sweden

8.7.9 Clinical Trial Regulation, Sweden

8.7.10 Pharmaceutical Clinical Trials Landscape, Sweden

8.7.11 Medical Devices Clinical Trials Landscape, Sweden

8.7.12 Pharmaceutical Export and Import, Sweden

8.7.13 Pharmaceutical Advertising Regulations, Sweden

8.7.14 Pharmaceutical Licensing Regulations, Sweden

8.7.15 Labeling and Packaging Regulations, Sweden

9. Country Healthcare Landscape

9.1 Swedish Healthcare Policy Highlights

9.2 Healthcare Facilities, Sweden

9.3 Life Expectancy and Immunization Rate, Sweden

9.4 Environmental Health, Sweden

9.5 Healthcare Personnel, Sweden

9.6 Disease Burden, Sweden

9.7 Healthcare Expenditure, Sweden

9.8 Healthcare Spending Components and Pharmaceutical Spending, Sweden

10 Trade Associations, Sweden

11 Trade Fairs, Sweden

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: Approved biosimilars, EU, 2020–21

Table 2: Likelihood of approval, EU

Table 3: COVID-19 indicators, global and Sweden, 2022

Table 4: Authorized COVID-19 vaccines, Sweden, 2020–22

Table 5: Marketed COVID-19 IVD products, Sweden, 2020–22

Table 6: Marketed COVID-19 IVD products, Sweden, 2020–22

Table 7: Medical devices market, major segments ($M), Sweden, 2021

Table 8: Hospital supplies market, revenue ($M) and market share (%) of major companies, Sweden, 2021

Table 9: Cardiovascular devices market, revenue ($M) and market share (%) of major companies, Sweden, 2021

Table 10: Orthopedic devices market, revenue ($M) and market share (%) of major companies, Sweden, 2021

Table 11: General surgery devices market, revenue ($M) and market share (%) of major companies, Sweden, 2021

Table 12: Wound care management market, revenue ($M) and market share (%) of major companies, Sweden, 2021

Table 13: Role of the healthcare authorities, Sweden, 2022

Table 14: Benefits associated with SSIA, Sweden, 2021

Table 15: Pricing of medicines at different levels, Sweden, 2022

Table 16: MA application type and fees, Sweden, 2022

Table 17: MA annual fees, Sweden, 2022

Table 18: Medical devices registration fees, Sweden, 2022

Table 19: Trademark fees, Sweden, 2022

Table 20: Advertising regulations, Sweden, 2022

Table 21: Advertising of pharmaceutical products through other mass media, Sweden, 2022

Table 22: Label of outer packaging and medicine containers, Sweden, 2022

Table 23: Label of pharmaceutical blister, Sweden, 2022

Table 24: Label of small pharmaceutical packaging, Sweden, 2022

Table 25: Trade fairs, Sweden, 2022

Figures

Figure 1: Pharmaceutical market, revenue ($B and SEKB), Sweden, 2015–22

Figure 2: Medical devices market, revenue ($B), Sweden, 2016–22

Figure 3: Healthcare start-ups in Sweden, 2022

Figure 4: Country profile, Sweden, 2021

Figure 5: Pharmaceutical market, revenue ($B and SEKB), Sweden, 2015–21

Figure 6: Pharmaceutical market, forecast revenue ($B and SEKB), Sweden, 2022–26

Figure 7: Pharmaceutical exports ($B), Sweden, 2013–21

Figure 8: Top export partners, Sweden, 2021

Figure 9: Pharmaceutical imports ($B), Sweden, 2013–21

Figure 10: Top import partners, Sweden, 2021

Figure 11: Number of outpatient pharmacies, Sweden, 2013–20

Figure 12: Pharmaceutical supply channel, Sweden, 2022

Figure 13: Major generic drug companies, Sweden, 2022

Figure 14: OTC medicines market, revenue ($B), Sweden, 2013–22

Figure 15: OTC medicines market, major categories ($M), Sweden, 2021

Figure 16: Major therapeutic areas by pharmaceutical consumption (DDD per 1,000 inhabitants per day), Sweden, 2019–21

Figure 17: Pharmaceutical market, sales of patented drug products (by major therapeutic class), Sweden, 2021

Figure 18: COVID-19 (cumulative number of cases), Sweden, 2020–22

Figure 19: COVID-19 (cumulative number of deaths), Sweden, 2020–22

Figure 20: COVID-19 Government Stringency Index, Sweden, 2020–22

Figure 21: COVID-19 Containment and Health Index, Sweden, 2020–22

Figure 22: COVID-19 vaccine dose administration (number of administered vaccine doses), Sweden, 2020–22

Figure 23: COVID-19 clinical trials sponsors by count, Sweden, 2020–22

Figure 24: COVID-19 clinical trials count by phase, Sweden, 2020–22

Figure 25: COVID-19 clinical trials count by trial status, Sweden, 2020–22

Figure 26: Medical devices market, revenue forecast ($B), Sweden, 2016–21

Figure 27: Medical devices market, revenue forecast ($B), Sweden, 2022–27

Figure 28: Medical devices market, major segments (%), Sweden, 2021

Figure 29: Hospital supplies market, revenue ($M), Sweden, 2017–27

Figure 30: Hospital supplies market, market share of major players (%), Sweden, 2021

Figure 31: Cardiovascular devices market, revenue ($M), Sweden, 2017–27

Figure 32: Cardiovascular devices market, market share of major players (%), Sweden, 2021

Figure 33: Orthopedic devices market, revenue ($M), Sweden, 2017–27

Figure 34: Orthopedic devices market, market share of major players (%), Sweden, 2021

Figure 35: General surgery devices market, revenue ($M), Sweden, 2017–27

Figure 36: General surgery devices market, market share of major players (%), Sweden, 2021

Figure 37: Wound care management market, revenue ($M), Sweden, 2017–27

Figure 38: Wound care management market, market share of major players (%), Sweden, 2021

Figure 39: Diagnostic market, revenue ($M), Sweden, 2016–21

Figure 40: Diagnostic market, revenue ($M), Sweden, 2022–27

Figure 41: Medical devices market, revenue ($B) of major companies, Sweden, 2021

Figure 42: Deals value and deal count, pharmaceutical market, Sweden, 2020–22

Figure 43: Deals value and deal count, subtypes, pharmaceutical market, Sweden, 2020–22

Figure 44: Deals value and deal count, quarterly, pharmaceutical market, Sweden, 2020–22

Figure 45: Top therapy areas by deal value ($M), pharmaceutical market, Sweden, 2020–22

Figure 46: PE deals by quarter (by value and by number), pharmaceutical market, Sweden, 2020–22

Figure 47: Top therapy areas by deal count, pharmaceutical market, Sweden, 2020–22

Figure 48: M&A deals by quarter (by value and by number), pharmaceutical market, Sweden, 2020–22

Figure 49: Deals value and deal count, medical devices market, Sweden, 2020–22

Figure 50: Deals value and deal count, quarterly, medical devices market, Sweden, 2020–22

Figure 51: Deals value and deal count, subtypes, medical devices market, Sweden, 2020–22

Figure 52: Top equipment sectors by deal value ($M), medical devices market, Sweden, 2020–22

Figure 53: Top equipment sectors by deal count, medical devices market, Sweden, 2020–22

Figure 54: M&A deals by value and by number (bi-annually), medical devices market, Sweden, 2020–22

Figure 55: PE deals by quarter, by value and by number (bi-annually), medical devices market, Sweden, 2020–22

Figure 56: Deals value ($B), HealthTech, Sweden, 2020–22

Figure 57: Deal count (number of deals), HealthTech, Sweden, 2020–22

Figure 58: GDPR compliance checklist, EU, 2022

Figure 59: Organization of healthcare system, Sweden, 2022

Figure 60: Drug funding and reimbursement approval process, Sweden, 2022

Figure 61: OOP expenditure (% of current expenditure on health), Sweden, 2013–20

Figure 62: Pharmaceutical price index, Sweden, 2014–22

Figure 63: Medical Products Agency (MPA), organization chart, Sweden, 2022

Figure 64: Drug authorization procedures, EU, 2022

Figure 65: Centralized procedure, Sweden, 2022

Figure 66: Decentralized procedure, Sweden, 2022

Figure 67: Mutual recognition procedure, Sweden, 2022

Figure 68: New drug approval process, Sweden, 2022

Figure 69: Marketing authorization for pharmaceutical products, Sweden, 2022

Figure 70: Conformity assessment of Class I medical devices, EU, 2022

Figure 71: Conformity assessment of Class IIa medical devices, EU, 2022

Figure 72: Conformity assessment of Class IIb medical devices, EU, 2022

Figure 73: Conformity assessment of Class III medical devices, EU, 2022

Figure 74: European patent approval process, EU, 2022

Figure 75: Unitary patent approval process, EU, 2022

Figure 76: Patent approval process, Sweden, 2022

Figure 77: Clinical trial process, Sweden, 2022

Figure 78: Pharmaceutical clinical trials count by trial status, Sweden, 2020–22

Figure 79: Pharmaceutical clinical trials count by phase, Sweden, 2020–22

Figure 80: Pharmaceutical clinical trials count by therapy areas, Sweden, 2020–22

Figure 81: Top five pharmaceutical clinical trials sponsors by count, Sweden, 2020–22

Figure 82: Medical devices clinical trials count by trial status, Sweden, 2020–22

Figure 83: Medical devices clinical trials count by indication, Sweden, 2020–22

Figure 84: Medical devices clinical trials count by therapeutic areas, Sweden, 2020–22

Figure 85: Top five medical devices clinical trials sponsors by count, Sweden, 2020–22

Figure 86: Number of hospital beds (per 1,000 population), Sweden, 2013–21

Figure 87: Number of diagnostic equipment units (per million population), Sweden, 2015–21

Figure 88: Immunization coverage (%), Sweden, 2013–20

Figure 89: Life expectancy at birth (years), Sweden, 2013–21

Figure 90: CO2 emissions (Mt CO2 per capita), Sweden, 2013–21

Figure 91: PM2.5 (µg per m3), Sweden, 2013–21

Figure 92: Physicians (per 1,000 population), Sweden, 2013–21

Figure 93: Pharmacists (per 1,000 population), Sweden, 2011–21

Figure 94: Nurses (per 1,000 population), Sweden, 2013–21

Figure 95: Dentists (per 1,000 population), Sweden, 2013–21

Figure 96: Major causes of male mortality (per 100,000 population), Sweden, 2021

Figure 97: Major causes of female mortality (per 100,000 population), Sweden, 2021

Figure 98: Healthcare expenditure as percentage of GDP (%), Sweden, 2013–21

Figure 99: Public-private share (% of total health spending), Sweden, 2013–21

Figure 100: Healthcare expenditure components by function (% of total health expenditure), Sweden, 2020

Figure 101: Pharmaceutical spending ($ per capita), Sweden, 2013–20

Frequently asked questions

Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape standard reports
Currency USD
$1,995

Can be used by individual purchaser only

Most Popular
$2,992

Can be shared by unlimited users within one corporate location e.g. a regional office

$3,990

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Pharmaceuticals reports
Pharmaceuticals
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Pharmaceuticals
New
Pharmaceutical Drug Development Annual Review 2025
$1,200 | August 2026
Pharmaceuticals
New
Q2 2026 CRO Activity and Intel Report
$1,870 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape in real time.

  • Access a live Sweden Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more